| Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters—a rat microdialysis and electrophysiology study AL Pehrson, T Cremers, C Bétry, MGC van der Hart, L Jørgensen, ... European Neuropsychopharmacology 23 (2), 133-145, 2013 | 181 | 2013 |
| Increased TSH in obesity: Evidence for a BMI-independent association with leptin C Bétry, MA Challan-Belval, A Bernard, A Charrié, J Drai, M Laville, ... Diabetes & metabolism 41 (3), 248-251, 2015 | 124 | 2015 |
| Role of 5-HT3 Receptors in the Antidepressant Response C Bétry, A Etiévant, C Oosterhof, B Ebert, C Sanchez, N Haddjeri Pharmaceuticals 4 (4), 603-629, 2011 | 85 | 2011 |
| The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT3 receptor antagonism C Bétry, AL Pehrson, A Etiévant, B Ebert, C Sánchez, N Haddjeri International Journal of Neuropsychopharmacology 16 (5), 1115-1127, 2013 | 73 | 2013 |
| Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory C Bétry, A Etiévant, A Pehrson, C Sánchez, N Haddjeri Progress in Neuro-Psychopharmacology and Biological Psychiatry 58, 38-46, 2015 | 64 | 2015 |
| Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats E Abrial, A Etievant, C Bétry, H Scarna, G Lucas, N Haddjeri, ... Progress in neuro-psychopharmacology and biological psychiatry 43, 40-48, 2013 | 62 | 2013 |
| Astroglial control of the antidepressant-like effects of prefrontal cortex deep brain stimulation A Etiévant, C Oosterhof, C Bétry, E Abrial, M Novo-Perez, R Rovera, ... EBioMedicine 2 (8), 898-908, 2015 | 57 | 2015 |
| An artificial neural network to predict resting energy expenditure in obesity E Disse, S Ledoux, C Bétry, C Caussy, C Maitrepierre, M Coupaye, ... Clinical Nutrition 37 (5), 1661-1669, 2018 | 48 | 2018 |
| Bariatric surgery outcomes in sarcopenic obesity D Mastino, M Robert, C Betry, M Laville, C Gouillat, E Disse Obesity surgery 26, 2355-2362, 2016 | 47 | 2016 |
| Need for intensive nutrition care after bariatric surgery: is mini gastric bypass at fault? C Bétry, E Disse, C Chambrier, D Barnoud, P Gelas, S Baubet, M Laville, ... Journal of Parenteral and Enteral Nutrition 41 (2), 258-262, 2017 | 42 | 2017 |
| Dilatation of sleeve gastrectomy: myth or reality? E Disse, A Pasquer, E Pelascini, PJ Valette, C Betry, M Laville, C Gouillat, ... Obesity surgery 27, 30-37, 2017 | 40 | 2017 |
| A 5-HT3 receptor antagonist potentiates the behavioral, neurochemical and electrophysiological actions of an SSRI antidepressant C Bétry, D Overstreet, N Haddjeri, AL Pehrson, C Bundgaard, C Sanchez, ... Pharmacology Biochemistry and Behavior 131, 136-142, 2015 | 36 | 2015 |
| Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation A Etievant, C Bétry, J Arnt, N Haddjeri Neuroscience letters 460 (1), 82-86, 2009 | 23 | 2009 |
| A series of severe neurologic complications after bariatric surgery in France: the NEUROBAR Study M Alligier, AL Borel, V Savey, C Rives-Lange, MC Brindisi, X Piguel, ... Surgery for Obesity and Related Diseases 16 (10), 1429-1435, 2020 | 16 | 2020 |
| Synergistic antidepressant-like action of gaboxadol and escitalopram T Christensen, C Bétry, O Mnie-Filali, A Etievant, B Ebert, N Haddjeri, ... European Neuropsychopharmacology 22 (10), 751-760, 2012 | 15 | 2012 |
| High expression of CPT1b in skeletal muscle in metabolically healthy older subjects C Bétry, E Meugnier, M Pflieger, G Grenet, S Hercberg, P Galan, ... Diabetes & metabolism 45 (2), 152-159, 2019 | 14 | 2019 |
| Partial dopamine D2/serotonin 5-HT1A receptor agonists as new therapeutic agents A Etievant, C Bétry, N Haddjeri The Open Neuropsychopharmacology Journal 3 (1), 2010 | 14 | 2010 |
| F15063, a potential antipsychotic with dopamine D2/D3 receptor antagonist, 5-HT1A receptor agonist and dopamine D4 receptor partial agonist properties: influence on neuronal … MB Assié, O Mnie-Filali, V Ravailhe, C Benas, M Marien, C Bétry, ... European journal of pharmacology 607 (1-3), 74-83, 2009 | 14 | 2009 |
| Hyperphagia in short bowel patients: Fat-free mass is a strong predictor C Bétry, M Lauverjat, T Mouillot, C Bergoin, D Barnoud, S Ait, ... Nutrition 62, 146-151, 2019 | 10 | 2019 |
| Deep brain stimulation as a therapeutic option for obesity: A critical review C Bétry, S Thobois, M Laville, E Disse Obesity Research & Clinical Practice 12 (3), 260-269, 2018 | 7 | 2018 |
Connie SanchezAlkermes在 alkermes.com 的电子邮件经过验证
